Patent 7119171 was granted and assigned to Research Corporation Technologies on October, 2006 by the United States Patent and Trademark Office.
The present invention provides modified fibronectin type III (Fn3) molecules, nucleic acid molecules encoding the modified Fn3 molecules, and related vectors and host cells.